Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.703
-0.017 (-2.29%)
At close: Nov 4, 2024, 4:00 PM
0.705
+0.002 (0.26%)
After-hours: Nov 4, 2024, 4:47 PM EST
Cosmos Health Employees
Cosmos Health had 123 employees as of December 31, 2023. The number of employees increased by 21 or 20.59% compared to the previous year.
Employees
123
Change (1Y)
21
Growth (1Y)
20.59%
Revenue / Employee
$458,983
Profits / Employee
-$234,145
Market Cap
12.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
Vivos Therapeutics | 123 |
BiomX | 71 |
Apollomics | 45 |
IN8bio | 31 |
Sensei Biotherapeutics | 28 |
COSCIENS Biopharma | 12 |
SeaStar Medical Holding | 12 |
COSM News
- 3 days ago - Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - Accesswire
- 5 weeks ago - Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands - Accesswire
- 6 weeks ago - Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - Accesswire
- 6 weeks ago - Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits - Accesswire
- 6 weeks ago - Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion - Accesswire
- 6 weeks ago - Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments - Accesswire
- 7 weeks ago - Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Accesswire
- 7 weeks ago - Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. - PRNewsWire